Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-10-16

Clinical Trial Update: Safety and Efficacy of Two Dosages of Diractin® in Osteoarthritis (OA) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two doses of Diractin in Osteoarthritis of the Knee has completed, with safety and efficacy data collected for analysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diractin (Ketoprofen)

Snippet

Sponsor: IDEA AG | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED